XM no presta servicios a los residentes de Estados Unidos de América.

Nasdaq eyes lower open as Nvidia, chips drag; inflation data in focus



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Nasdaq eyes lower open as Nvidia, chips drag; inflation data in focus</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Fed's preferred inflation PCE data due on Friday

Under Armour falls after agreeing on lawsuit payout

ResMed slumps on Lilly's sleep apnea trial for weight-loss drug

Futures: Dow up 0.20%, S&P 500 flat, Nasdaq down 0.27%

Updated at 8:34 a.m. ET/1234 GMT

By Ankika Biswas and Lisa Pauline Mattackal

June 24 (Reuters) - The Nasdaq was set to open lower on Monday after Nvidia and other chip stocks remained under selling pressure, with investors on tenterhooks as a key inflation print this week could further shape bets over the timing and quantum of rate cuts.

AI chip leader Nvidia NVDA.O dropped 2.3% premarket following a near 7% slide over the past two sessions after briefly becoming the world's most valuable company last week.

"Nvidia has run incredibly fast and hard since the (stock) split. I don't think that the price rise was merited by fundamentals, so the price falling doesn't really mean anything either," said Kim Forrest, chief investment officer at Bokeh Capital Partners.

Some other semiconductor stocks including Arm Holdings ARM.O, Qualcomm QCOM.O, U.S.-listed shares of Taiwan Semiconductor Manufacturing TSM.N and Applied Materials AMAT.O were down between 1% and 2%.

The biggest event on investors' radar for the week is Friday's personal consumption expenditures (PCE) price index report- the Federal Reserve's preferred measure of inflation, expected to show a moderation in price pressures.

"The PCE could drive the market higher if it's even a little bit lower than anticipated ... The Fed has every reason to try to cut, but they don't really want to talk about it because they need to be tough on inflation" Forrest added.

Market participants are still expecting about two rate cuts this year, pricing in an over 60% chance of a 25-basis-point cutin September, asper LSEG's FedWatch.

The data comes againstthe backdrop of investors weighing the moderation in recent inflation data against the Fed's latest projection of one rate cut likely in December.

Investors also awaited remarks from Fed voting committee member and San Francisco President Mary Daly during the day, in light of the narrative of higher-for-longer interest rates maintained by several Fed policymakers.

The S&P 500 posted its third straight weekly gain and the blue-chip Dow .DJI its strongest weekly performance in six in the previous week, which saw simultaneous expiration of stock and index derivative contracts, quarterly S&P 500 rebalancing and mixed economic data.

The other events lined up for the week include durable goods, weekly jobless claims and final first-quarter GDP figures, along with quarterly earnings from the likes of FedEx FDX.N, Micron Technology MU.O and Walgreens Boots Alliance WBA.O.

Further, PresidentJoe Biden will debate rival Donald Trump in Atlanta on Thursday, with both neck-and-neck in national opinion polls, as a considerable slice of the electorate remains undecided over four months before the Nov. 5 vote.

At 8:34 a.m. ET, Dow e-minis 1YMcv1 were up 81 points, or 0.2%, S&P 500 e-minis EScv1 were down 1.75 points, or 0.03%, and Nasdaq 100 e-minis NQcv1 were down 53.25 points, or 0.27%.

Under Armour UAA.N dropped 1.6% after the sports apparel maker agreed to pay $434 million to settle a 2017 class action lawsuit over sales disclosures.

Respiratory device maker ResMed RMD.N slumped 9.6% after Eli Lilly LLY.N said its popular weight-loss drug Zepbound helped resolve moderate-to-severe obstructive sleep apnea in up to 52% of patients in two late-stage trials.

Affirm Holdings AFRM.O rose 3.4% after a report thatGoldman Sachs assumed coverage of the buy now, pay later firm with a "buy" rating.



Reporting by Ankika Biswas and Lisa Mattackal in Bengaluru; Editing by Maju Samuel

</body></html>

Descargo de responsabilidades: Cada una de las entidades de XM Group proporciona un servicio de solo ejecución y acceso a nuestra plataforma de trading online, permitiendo a una persona ver o usar el contenido disponible en o a través del sitio web, sin intención de cambiarlo ni ampliarlo. Dicho acceso y uso están sujetos en todo momento a: (i) Términos y Condiciones; (ii) Advertencias de riesgo; y (iii) Descargo completo de responsabilidades. Por lo tanto, dicho contenido se proporciona exclusivamente como información general. En particular, por favor tenga en cuenta que, los contenidos de nuestra plataforma de trading online no son ni solicitud ni una oferta para entrar a realizar transacciones en los mercados financieros. Operar en cualquier mercado financiero implica un nivel de riesgo significativo para su capital.

Todo el material publicado en nuestra plataforma de trading online tiene únicamente fines educativos/informativos y no contiene –y no debe considerarse que contenga– asesoramiento ni recomendaciones financieras, tributarias o de inversión, ni un registro de nuestros precios de trading, ni una oferta ni solicitud de transacción con instrumentos financieros ni promociones financieras no solicitadas.

Cualquier contenido de terceros, así como el contenido preparado por XM, como por ejemplo opiniones, noticias, investigaciones, análisis, precios, otras informaciones o enlaces a sitios de terceros que figuran en este sitio web se proporcionan “tal cual”, como comentarios generales del mercado y no constituyen un asesoramiento en materia de inversión. En la medida en que cualquier contenido se interprete como investigación de inversión, usted debe tener en cuenta y aceptar que dicho contenido no fue concebido ni elaborado de acuerdo con los requisitos legales diseñados para promover la independencia en materia de investigación de inversiones y, por tanto, se considera como una comunicación comercial en virtud de las leyes y regulaciones pertinentes. Por favor, asegúrese de haber leído y comprendido nuestro Aviso sobre investigación de inversión no independiente y advertencia de riesgo en relación con la información anterior, al que se puede acceder aquí.

Advertencia de riesgo: Su capital está en riesgo. Los productos apalancados pueden no ser adecuados para todos. Por favor, tenga en cuenta nuestra Declaración de riesgos.